Avastin wins full green light for glioblastoma
admin 7th December 2017 Uncategorised 0Roche group Genentech has announced full US approval for Avastin for the treatment of adults with glioblastoma that progressed following prior therapy.
More: Avastin wins full green light for glioblastoma
Source: News